BLFS BioLife Solutions, Inc.
$34.95▲ +0.09%
Healthcare
Other
After hours
$34.95▲ +0.00%
Sep 11, 7:30 PM ET
Volume 863.3K
Avg Volume (10D) 990.3K
Key Metrics & Fundamentals
Market Cap
$1.71B
P/E Ratio
35.0
Div Yield
–%
52W Range
17.86 - 38.10
% vs 50 MA
6.15%
% vs 200 MA
36.26%
RSI-14
50.6
MACD Histogram
-0.4400
Beta (1Y vs SPY)
1.15
Free Cash Flow
$5.19M
Gross Rev
$28.47M
Gross Profit
$18.29M
EBITDA
$2.51M
COGS
$10.18M
Operating Exp
$16.59M
Operating Income
$1.70M
EBIT
$1.70M
Pretax Income
$2.75M
Net Income
$45.10M
EPS (Diluted)
0.91
Price & Volume History
Loading chart…
Recent News
Diamond Hill Bets on BioLife Solutions’ (BLFS) High Switching Cost
Insider Monkey · Sep 4, 2026 2:31 PM
BioLife Solutions (BLFS) Is Up 7.2% After Swinging From Loss To Q2 Profit - What's Changed
Simply Wall St. · Aug 7, 2026 8:13 AM
BioLife Solutions, Inc. (BLFS) Q2 Earnings and Revenues Surpass Estimates
Zacks · Aug 6, 2026 9:40 PM
BioLife Solutions Reports Second Quarter 2026 Financial Results
PR Newswire · Aug 6, 2026 8:03 PM
Repligen (RGEN) Held An M&A Call With BioLife Solutions.
Simply Wall St. · Jul 28, 2026 8:12 PM
Repligen Reports Q2 Revenue Growth and Raises Full-Year 2026 Guidance
InvestorsHub · Jul 28, 2026 2:05 PM
Repligen to Expand Cell Therapy Capabilities With BioLife Buyout
Zacks · Jul 23, 2026 3:36 PM
Jefferies Downgrades BioLife Solutions to Hold From Buy, Adjusts Price Target to $31 From $30
MT Newswires · Jul 23, 2026 1:31 PM
Craig Hallum Downgrades BioLife Solutions to Hold From Buy, Trims Price Target to $31 From $32
MT Newswires · Jul 23, 2026 11:27 AM
TD Cowen Downgrades BioLife Solutions to Hold From Buy, Trims Price Target to $31 From $33
MT Newswires · Jul 23, 2026 11:26 AM
Financial Overview - Income Statement
Quarterly
Jun 2026
See BLFS's money flow as a full page
Social Sentiment
No Reddit posts found for BLFS.
AI Analysis
Click Generate Analysis for an AI-powered summary, bull & bear case, and recent performance review.
Not financial advice.
All data, scores, charts, and analysis on this site are provided for informational and educational
purposes only and do not constitute financial, investment, legal, or tax advice.
Past performance is not indicative of future results.
See our Legal Notice for full details.